Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC5135 Chaetominine
Chaetominine , an alkaloidal metabolite with a new framework, was characterized from the solid-substrate culture of Chaetomium sp.
More description
DC20337 Chaetocin
Chaetocin is a potent, specific, SAM-competitive inhibitor of histone H3K9 methyltransferase (HMT) SU(VAR)3-9 with IC50 of 0.6 uM, no actiivty against H4 Lys20-specific HMT PRSET7 and SET7/9.
More description
DC10974 Ch-319
Ch-319 (Ch319) is a triphenyltin (IV) carboxylate derivative that modulates AKT/FOXO3a signaling and inhibits progression of prostate cancer.
More description
DC21331 CGS 27023A
CGS 27023A (MMI 270) is a potent, orally active MMP inhibitor with Ki of 8-43 nM for MMP1/2/3/9.
More description
DC24112 CGS 21680
CGS 21680 is a specific adenosine A2A subtype receptor agonist with Ki of 27 nM.
More description
DC20887 CGP-74514A hydrochloride
CGP-74514A hydrochloride is a potent CDK1 inhibitor with IC50 of 25 nM.
More description
DC23830 CGP-53353
CGP-53353 (DAPH-7) is a selective inhibitor of PKCβII with IC50 of 0.41 uM, shows weak activity on PKCβI with IC50 of 3.8 uM.
More description
DC9849 CGP37849
CGP37849 is a potent, selective and competitive NMDA receptor antagonist (Ki = 35 nM). Anticonvulsive following oral administration in vivo.
More description
DC11133 CFM-4.16
CFM-4.16 is a CARP-1 functional mimetic (CFM) compound bind with CARP-1, stimulates CARP-1 expression and apoptosis.
More description
DC9340 CFM-2
CFM-2 is a selective non-competitive AMPAR antagonist.
More description
DC23338 CFI-401980
CFI-401980 is a potent, selective, novel class TTK (Tyrosine Threonine Kinase) inhibitor with Ki of 0.8 nM, HCT116 GI50 of 13 nM.
More description
DC22052 CFI02
CFI02 (CFI-02) is a specific inhibitor of human cytomegalovirus (HCMV) glycoprotein B-mediated fusion with IC50 of 40 nM against laboratory adapted HCMV strain AD169.
More description
DC7899 Cevipabulin(TTI 237)
Cevipabulin, also known as TTI-237, an antimicrotubule agent, is a small synthetic molecule of triazolopyrimidine derivative with potential antitumor activity.
More description
DC10226 Cefradine
Cephradine is a semi-synthetic cephalosporin antibiotic.
More description
DC23856 CEP-7055
CEP-7055 is a potent, orally active, pan inhibitor of VEGFR, CEP-7055 is the dimethylglycine ester prodrug of CEP-5214, which inhibits human VEGFR2/KDR kinase, VEGFR1/FLT-1 kinase, and VEGFR3/FLT-4 kinase with IC50 of 18 nM, 12 nM, and 17 nM.
More description
DC8777 CEP-32496 hydrochloride
CEP-32496 Hcl is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/36 nM and 39 nM, also potent to Abl-1, c-Kit, Ret, PDGFRβ and VEGFR2, respectively; insignificant affinity for MEK-1, MEK-2, ERK-1 and ERK-2.
More description
DC22796 CEP-1347
CEP-1347 (KT-7515) is a potent and selective MLK inhibitor that completely rescues motoneurons and inhibits JNK1 activation with IC50 of 20 nM.
More description
DC12319 Centanafadine (EB-1020)
Centanafadine is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively.
More description
DC12318 Centanafadine hydrochloride (EB-1020 (hydrochloride))
Centanafadine (hydrochloride) is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively.
More description
DC21554 AS 703569
Cenisertib (AS 703569;R763) is a novel potent, orally available inhibitor of Aurora kinases, exhibits signifficant anti-proliferative activity against a wide range of tumor cells both in vitro and in vivo (A549 EC50=9 nM).
More description
DC10357 Cenerimod
Cenerimod (ACT-334441) is a potent and orally available sphingosine 1-phosphate 1 receptor (S1P1) agonist extracted from patent WO 2016184939 A1 and WO 2011007324 A1, example 1, with an EC50 of 2.7 nM.
More description
DC23359 CeMMEC2
CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM, binds to both bromodomains of BRD4, comparably to (S)-JQ1..
More description
DC7569 Z-LEHD-FMK
Cell permeable fluoromethyl ketone (FMK)-derivatized peptides act as effective irreversible Caspase inhibitors with no cytotoxic effects and, therefore, are useful tools for studying Caspase activity.
More description
DC12245 Ceftizoxime
Ceftizoxime is a bacterial inhibitor which acts by interfering with bacterial cell wall synthesis and inhibiting cross-linking of the peptidoglycan.
More description
DC9355 Ceftibuten (dihydrate)
Ceftibuten dihydrate is a third-generation cephalosporin antibiotic.
More description
DC8687 Cefpirome sulfate
Cefpirome Sulfate is a fourth generation cephalosporin antibiotic.
More description
DC9356 Cefpiramide (sodium)
Cefpiramide sodium (SM-1652; Wy-44635) is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity.
More description
DC20190 Cefoxitin
Cefoxitin is a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity.
More description
DC9358 Cefmenoxime (hydrochloride)
Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic.
More description
DC8686 Cefetamet pivoxil hydrochloride
Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X